Clinical Research Directory
Browse clinical research sites, groups, and studies.
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
Sponsor: China National Center for Cardiovascular Diseases
Summary
This multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K antagonist combined with aspirin in terms of safety and efficacy.
Official title: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump (STAR Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
370
Start Date
2026-06-25
Completion Date
2029-12-31
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Interventions
Warfarin (INR 2-3) with placebo
Warfarin (INR 2-3) with placebo
Warfarin (INR 2-3) with aspirin
Warfarin (INR 2-3) with aspirin